logo

For the Inventor, By the Inventor

Toyama, Japan

Isamu Takakura

USPTO Granted Patents = 11

Average Co-Inventor Count = 7.7

ph-index = 4

Forward Citations = 44(Granted Patents)


Company Filing History:

goldMedal11 out of 159 
 
Toyama Chemical Co., Ltd.
 patents

Years Active: 1978-1999

Loading Chart...
11 patents (USPTO):Explore Patents
1. 5858408 - Sustained-release oral ointment (1999-01-12),
2. 4395412 - 7.alpha.-Methoxycephalosporins (1983-07-26),
3. 4385178 - Process for producing 7-(substituted)amino-3-substituted thiomethyl (1983-05-24),
4. 4321265 - 7.alpha.-Methoxycephalosporins (1982-03-23),
5. 4317907 - Process for producing 7-(substituted)amino-3-substituted thiomethyl (1982-03-02),
6. 4312986 - Process for producing 7-(substituted)amino-3-substituted (1982-01-26),
7. 4304909 - Process for producing (1981-12-08),
8. 4263292 - 7.alpha.-methoxycephalosporins and pharmaceutical composition comprising (1981-04-21),
9. 4237280 - Intermediate for cephalosporin type compound (1980-12-02),
10. 4200744 - Substituted (1980-04-29),
11. 4129730 - 7.alpha.-Methoxy-cephalosporins (1978-12-12),

Title: Isamu Takakura: Innovator in Antibacterial Compounds

Introduction

Isamu Takakura is a prominent inventor based in Toyama, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of antibacterial compounds. With a total of 11 patents to his name, Takakura's work has had a substantial impact on medical science.

Latest Patents

One of Takakura's latest patents is for a sustained-release oral ointment that features a 7.alpha.-methoxycephalosporin. This compound is represented by a specific general formula, where R.sup.1 can be a hydrogen atom or a carboxyl-protecting group, and R.sup.2 is an organic group linked through an oxygen or sulfur atom. The compound exhibits a broad antibacterial spectrum and high resistance to .beta.-lactamase produced by bacteria, making it effective against clinical isolates.

Career Highlights

Takakura is associated with Toyama Chemical Co., Ltd., where he has been instrumental in advancing research and development in antibacterial agents. His innovative approach has led to the creation of compounds that are not only effective but also have a significant impact on treating bacterial infections.

Collaborations

Throughout his career, Takakura has collaborated with notable colleagues, including Isamu Saikawa and Shuntaro Takano. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Isamu Takakura's contributions to the field of pharmaceuticals, particularly in antibacterial compounds, highlight his role as a leading inventor. His work continues to influence medical science and improve treatment options for bacterial infections.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…